Atlas Trials

Tissue Collection for Biomarkers Determining Resistance to Ibrutinib

Clinical trial NCT02267590 · UNKNOWN

Trial details

NCT number
NCT02267590
Sponsor
Royal Marsden NHS Foundation Trust
Status
UNKNOWN
Study type
OBSERVATIONAL
Mantle Cell LymphomaChronic Lymphocytic Leukaemia
Start date
2014-10-01
Primary completion
2016-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.